Reduce the risk of drug-induced tardive syndromes by minimizing exposure to dopamine receptor blocking agents whenever possible
Crossref DOI link: https://doi.org/10.1007/s40267-016-0331-4
Published Online: 2016-07-29
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
License valid from 2016-07-29
